Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release.

Drug targeting to the colon via the oral administration route for local treatment of e.g. inflammatory bowel disease and colonic cancer has several advantages such as needle-free administration and low infection risk. A new source for delivery is plant-polysaccharide based delivery platforms such as...

Full description

Bibliographic Details
Main Authors: Anna J Svagan, Anja Kusic, Cristian De Gobba, Flemming H Larsen, Philip Sassene, Qi Zhou, Marco van de Weert, Anette Mullertz, Bodil Jørgensen, Peter Ulvskov
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5167381?pdf=render

Similar Items